misleading statements

Rosen Law Firm sues Enphase Energy for allegedly misrepresenting inventory management and overstating financial outlook regarding tax credit impacts.

Oracle faces a securities class action lawsuit over allegedly misleading AI strategy disclosures. Investors must act by April 6, 2026, regarding stock purchased between June-December 2025.

Picard Medical securities lawsuit filing deadline is April 13, 2026. Class action alleges fraudulent stock promotion, insider selling, and artificial trading.

Rosen Law Firm filed a securities class action against Ramaco Resources for allegedly making false statements about its Brook Mine operations between July and October 2025.

Class action lawsuits filed against PomDoctor and Vistagen Therapeutics alleging securities violations. Vistagen's stock fell 80% after failed clinical trial results.

Varonis faces class action lawsuit over allegedly misleading statements about revenue sustainability. Investors have until March 9 to join after stock plunged 48.7%.

Rosen Law Firm seeks lead plaintiff for PomDoctor securities class action by April 7, 2026. Investors alleging losses from fraudulent promotion and misleading statements can apply.

Rosen Law Firm urges Agilon Health investors with losses over $100,000 to join securities class action before March 2026 deadline. Lawsuit alleges false financial guidance.

Corcept Therapeutics faces class action lawsuit over alleged misrepresentation regarding relacorilant drug. FDA rejected the application citing insufficient efficacy data; stock plummeted over 50%.

Vistagen investors face March 16, 2026 deadline in securities lawsuit alleging false statements about drug trials and clinical data that misled shareholders.

Class action lawsuit filed against REGENXBIO for allegedly making false statements about gene therapy safety and efficacy while withholding adverse trial information from investors.

PayPal faces class action lawsuit alleging false statements about Branded Checkout growth prospects. Investors who purchased securities Feb 2025-Feb 2026 invited to join litigation.

Mereo BioPharma faces class action lawsuit over allegedly false statements regarding failed Phase 3 clinical trials. Investors who bought securities between June 2023-December 2025 may be eligible to participate.

uniQure faces securities class action lawsuit over allegedly false FDA approval statements. Investors who purchased stock between September-October 2025 can join the case by April 2026.

Rosen Law Firm sues PomDoctor Ltd. for stock promotion fraud and misleading statements. Investors must act by April 7, 2026 deadline to join the class action.

Law firm investigates Gemini Space Station for alleged securities violations after three senior executives departed unexpectedly, causing stock to drop 12.9%.

PayPal faces class action lawsuit for allegedly making false statements about 2027 financial targets and Branded Checkout capabilities. Affected investors urged to seek legal counsel promptly.

Mereo BioPharma faces securities litigation alleging it misled investors about Phase 3 clinical trial results for setrusumab, failing to disclose the trials missed primary endpoints.

Klarna faces securities class action over allegedly misleading IPO statements about loss reserves. Lead plaintiff deadline set for February 20, 2026.

Law firm sues China Liberal Education Holdings for securities fraud, alleging misleading statements about share manipulation in January 2025. Seeking lead plaintiffs from affected investors.